Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct;25(5):551-5.
doi: 10.1016/j.coi.2013.09.014.

A systems framework for vaccine design

Review

A systems framework for vaccine design

Michael Mooney et al. Curr Opin Immunol. 2013 Oct.

Abstract

Numerous challenges have been identified in vaccine development, including variable efficacy as a function of population demographics and a lack of characterization and mechanistic understanding of immune correlates of protection able to guide delivery and dosing. There is tremendous opportunity in recent technological and computational advances to elucidate systems level understanding of pathogen-host interactions and correlates of immunity. A systems biology approach to vaccinology provides a new paradigm for rational vaccine design in a ‘precision medicine’ context.

PubMed Disclaimer

Figures

Figure 1
Figure 1
System-level approach to vaccine development from bench to bedside. The integration of multi-omic measurements (proteomic, transcriptomic, etc.) along with information about host–pathogen interactions will allow for a system-level view of the host reponse to infection (or vaccination). Analysis with network-based approaches (module identification, differential network analysis, etc.) will enable discoveries about the host immune response, including insights into the mechanism of action of vaccines, biomarkers of immune protection, and potentially new vaccine candidates (targets), leading to improved vaccine development and delivery.

Similar articles

Cited by

References

    1. Rueckert C., Guzmán C.A. Vaccines: from empirical development to rational design. PLoS Pathog. 2012;8:e1003001. - PMC - PubMed
    1. Poland G.A., Kennedy R.B., McKinney B.A., Ovsyannikova I.G., Lambert N.D., Jacobson R.M., Oberg A.L. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. Semin Immunol. 2013;25:89–103. - PMC - PubMed
    1. Poland G.A., Ovsyannikova I.G., Kennedy R.B., Haralambieva I.H., Jacobson R.M. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. OMICS. 2011;9:625–636. - PMC - PubMed
    1. Li S., Nakaya H.I., Kazmin D.A., Oh J.Z., Pulendran B. Systems biological approaches to measure and understand vaccine immunity in humans. Semin Immunol. 2013 [epub ahead of print] - PMC - PubMed
    1. Wang C.C., Zhu B., Fan X., Gicquel B., Zhang Y. Systems approach to tuberculosis vaccine development. Respirology. 2013;3:412–420. - PubMed

Publication types